Moderna's combo flu and Covid jab boosts protection
The Guardian — June 10, 2024, 03:00 PM UTC
Summary: A clinical trial by Moderna shows a combined flu and Covid vaccine elicits higher immune responses than separate shots. Results from a phase 3 trial of 8,000 participants indicate increased protection against both diseases. Moderna aims to make the vaccine widely available next year. CEO Stéphane Bancel highlights the potential of combination vaccines in reducing respiratory virus burdens. Boots in England offers Pfizer-BioNTech jabs for £98.95 to customers aged 12 and over.
Article metrics
The article metrics are deprecated.
I'm replacing the original 8-factor scoring system with a new and improved one. It doesn't use the original factors and gives much better significance scores.